Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 7/20 | 0.35 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL1293248 | 0.84 | GPR3 (0.39) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL2773916 | 0.82 | KCNH2 (0.36) | KCNH2ACHEGPR3 | |
| Sulfuric Acid SCHEMBL7636624 | 0.81 | TP53 (0.38) | — | |
| Sulfuric Acid SCHEMBL21195061 | 0.78 | TP53 (0.36) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL6746359 | 0.78 | KCNH2 (0.34) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL1293304 | 0.78 | KCNH2 (0.41) | KCNH2ACHE | |
| SCHEMBL30977282 | 0.76 | — | — | |
| Sulfuric Acid SCHEMBL21195062 | 0.76 | TSHR (0.44) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL15667318 | 0.76 | KCNH2 (0.38) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL7089273 | 0.76 | GPR3 (0.35) | KCNH2ACHEGPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | XU KANG (US) | 2004-11-11 | — | — | US | claimed |
| EP-3042939-B1 | ADHESIVE COMPOSITION | TOAGOSEI CO LTD (JP) | 2021-06-23 | — | — | EP | disclosed |
| EP-3042933-B1 | CURABLE RESIN COMPOSITION | TOAGOSEI CO LTD (JP) | 2020-09-30 | — | — | EP | disclosed |
| WO-2020071553-A1 | ADHESIVE COMPOSITION FOR ASSEMBLING SPEAKER, METHOD FOR ASSEMBLING SPEAKER, AND SPEAKER | 東亞合成株式会社 | 2020-04-09 | — | — | WO | disclosed |
| EP-3231818-B1 | TWO-PART CURABLE COMPOSITION | TOAGOSEI CO LTD (JP) | 2019-08-14 | — | — | EP | disclosed |
| US-9994662-B2 | Two-part curable composition | TOAGOSEI CO., LTD. (JP) | 2018-06-12 | — | — | US | disclosed |
| EP-2933302-B1 | ADHESIVE COMPOSITION | TOAGOSEI CO LTD (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-9932447-B2 | Curable resin composition | TOAGOSEI CO., LTD. (JP) | 2018-04-03 | — | — | US | disclosed |
| US-20170327616-A1 | TWO-PART CURABLE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| EP-3231818-A1 | TWO-PART CURABLE COMPOSITION | Toagosei Co., Ltd. (JP) | 2017-10-18 | — | — | EP | disclosed |
| US-20130316248-A9 | Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups | IGNATYEV NIKOLAI (DE) | 2013-11-28 | — | — | US | disclosed |
| US-20090269673-A1 | Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups | IGNATYEV NIKOLAI | 2009-10-29 | — | — | US | disclosed |
| US-7585994-B2 | used in electrolytes, batteries, capacitors, supercapacitors, and galvanic cells; N,N-dimethylpyrrolidinium trifluoromethanesulfonate; methyl(triethyl)phosphonium trifluoromethanesulfonate | MERCK PATENT GMBH (DE) | 2009-09-08 | — | — | US | disclosed |
| EP-1399417-B1 | METHOD FOR PRODUCING PERFLUOROALKANESULFONIC ACID ESTERS | MERCK PATENT GMBH (DE) | 2009-08-12 | — | — | EP | disclosed |
| EP-2085378-A1 | Perfluor alkane sulphonic acid salts | Merck Patent GmbH (DE) | 2009-08-05 | — | — | EP | disclosed |
| US-20060217568-A1 | used in electrolytes, batteries, capacitors, supercapacitors, and galvanic cells; N,N-dimethylpyrrolidinium trifluoromethanesulfonate; methyl(triethyl)phosphonium trifluoromethanesulfonate | IGNATYEV NIKOLAI | 2006-09-28 | — | — | US | disclosed |
| US-7084290-B2 | Method for producing perfluoroalkanesulfonic acid esters | MERCK PATENT GMBH (DE) | 2006-08-01 | — | — | US | disclosed |
| US-20040158091-A1 | Method for producing perfluoroalkanesulfonic acid esters | MERCK PATENT GMBH (DE) | 2004-08-12 | — | — | US | disclosed |
| EP-1399417-A1 | METHOD FOR PRODUCING PERFLUOROALKANESULFONIC ACID ESTERS | MERCK PATENT GmbH (DE) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002098844-A1 | METHOD FOR PRODUCING PERFLUOROALKANESULFONIC ACID ESTERS | MERCK PATENT GMBH (DE) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217568-A1 | used in electrolytes, batteries, capacitors, supercapacitors, and galvanic cells; N,N-dimethylpyrrolidinium trifluoromethanesulfonate; methyl(triethyl)phosphonium trifluoromethanesulfonate | PFKFB2, PFKFB4, PFKFB3 | KCNH2 148/4885ACHE 2610/4885GPR3 1267/4885 |
| US-20130316248-A9 | Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups | PFAS, PFKFB2, PFKFB4 | KCNH2 55/4885ACHE 3596/4885GPR3 766/4885 |
| US-20090269673-A1 | Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups | PFAS, PFKFB2, PFKFB4 | KCNH2 55/4885ACHE 3596/4885GPR3 766/4885 |
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | VDAC2, VDAC1, HCN2 | KCNH2 86/4885ACHE 679/4885GPR3 4228/4885 |
| US-20040158091-A1 | Method for producing perfluoroalkanesulfonic acid esters | PFAS, PFKFB2, PFKFB4 | KCNH2 132/4885ACHE 3148/4885GPR3 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.